Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Director's Dealing 2010

Apr 11, 2010

33869_rns_2010-04-11_0f68098c-866b-486d-a3b7-d180ff368e4a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [595 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433

www.biomd.com.au

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 4 pages

12 April 2010

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of changes to the notifiable interests of directors in accordance with Listing Rule 3.19A.2 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of the change in holding as a result of the allotment of options under the recent Rights Issue.

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [595 x 42] intentionally omitted <==

APPENDIX 3Y

CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 088 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Towner Date of last notice: 25 January 2010

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Towner is a director of companies holding BODOA Date of change: 12 April 2010 No. of securities held prior to change: Nil Class: Options (BODOA) Number acquired: 4,539,661 (indirect), 3,791,667 (direct) and 7,311,251 (nominee) Number disposed: Nil Value/Consideration: $234,638.70 No. of securities held after change: 4,539,661 (indirect), 3,791,667 (direct) and 7,311,251 (nominee) Nature of the change: Rights issue of options PART 2 – Change of director’s interests in contracts Details of contract: None Applicable Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change:

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 088 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Scott
Date of last notice: 7 April 2009
PART 1– Change of director's relevant interests in securities
Direct or indirect interest: Indirect
Nature of indirect interest: Mr Scott is a director of companies holding BODOA
Date of change: 12 April 2010
**No. of securities held prior to change: **Nil
Class: Options (BODOA)
Number acquired: 390,750
Number disposed: Nil
Value/Consideration: $5,861.25
No. of securities held after change: 390,750
Nature of the change: Rights issue of options
PART 2– Change of director’s interests in contracts
Details of contract: None Applicable
Nature of interest:
Name of registered holder:
(if issued securities)
No. and class of securities to which interest relates:
Interest acquired:
Interest disposed:
Value/Consideration:
Interest after change:

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Michael Bennett
Date of last notice: 7 April 2009
PART 1– Change of director's relevant interests in securities
Direct or indirect interest: Direct
Nature of indirect interest: N/A
Date of change: 12 April 2010
**No. of securities held prior to change: ** Nil
Class: Options (BODOA)
Number acquired: 1,000,000
Number disposed: Nil
Value/Consideration: $15,000.00
No. of securities held after change: 1,000,000
Nature of the change: Rights issue of options
PART 2– Change of director’s interests in contracts
Details of contract: None Applicable
Nature of interest:
Name of registered holder:
(if issued securities)
No. and class of securities to which interest relates:
Interest acquired:
Interest disposed:
Value/Consideration:
Interest after change: